These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32493679)

  • 21. Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study.
    Capocci M; Romeo U; Guerra F; Mannocci A; Tenore G; Annibali S; Ottolenghi L
    Clin Ter; 2017; 168(4):e253-e257. PubMed ID: 28703840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the quality of life of patients with medication-related osteonecrosis of the jaw during treatment: A quality-of-life survey and causal analysis.
    Munakata K; Miyashita H; Yamada Y; Soma T; Iwasaki R; Nakagawa T; Asoda S
    J Craniomaxillofac Surg; 2024 Jun; 52(6):715-721. PubMed ID: 38582669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Ogura I; Minami Y; Ono J; Kanri Y; Okada Y; Igarashi K; Haga-Tsujimura M; Nakahara K; Kobayashi E
    Imaging Sci Dent; 2021 Mar; 51(1):73-80. PubMed ID: 33828964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
    Toshima H; Ogura I
    Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis.
    Murphy J; Mannion CJ
    Br J Oral Maxillofac Surg; 2020 Jul; 58(6):619-624. PubMed ID: 32247520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.
    Miranda-Silva W; Montezuma MA; Benites BM; Bruno JS; Fonseca FP; Fregnani ER
    Support Care Cancer; 2020 Nov; 28(11):5397-5404. PubMed ID: 32144584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-Rich Fibrin Treatment Evaluation in Patients with Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.
    Roman RC; Moldovan MA; Pop LS; Megieșan S; Faur CI
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930013
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation of clindamycin concentrations in human plasma and jawbone tissue in patients with osteonecrosis of the jaw: A prospective trial.
    Straub A; Stapf M; Brands RC; Kübler AC; Lâm TT; Vollmer A; Gubik S; Scherf-Clavel O; Hartmann S
    J Craniomaxillofac Surg; 2024 Mar; 52(3):355-362. PubMed ID: 38368214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
    De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
    Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study.
    Winter A; Schulz SM; Schmitter M; Brands RC; Straub A; Kübler A; Borgmann A; Hartmann S
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral-Health-Related Quality of Life After Surgical Treatment of Osteonecrosis of the Jaws.
    Oteri G; De Ponte FS; Runci M; Peditto M; Marcianò A; Cicciù M
    J Craniofac Surg; 2018 Mar; 29(2):403-408. PubMed ID: 29135723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication--related osteonecrosis of the jaws. The first reported cases in the Baltic States and a literature review.
    Zaleckas L; Stacevičius M; Proškutė D; Povilaitytė J
    Stomatologija; 2015; 17(3):89-96. PubMed ID: 26879401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Osteonecrosis of the Jaw.
    Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
    J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m hydroxymethylene diphosphonate scintigraphy, computed tomography, and magnetic resonance imaging of osteonecrosis in the mandible: Osteoradionecrosis versus medication-related osteonecrosis of the jaw.
    Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
    Imaging Sci Dent; 2019 Mar; 49(1):53-58. PubMed ID: 30941288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstruction of mandibular defects in osteoradionecrosis and medication-related osteonecrosis of the jaw using fibula free flap and management of postoperative wound infections.
    Oh H; Kwon D; Ahn J; Paeng JY
    Maxillofac Plast Reconstr Surg; 2022 Dec; 44(1):37. PubMed ID: 36484930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of medication-related osteonecrosis of the jaws on the quality of life in cancer patients.
    Caminha RD; Alcantara PL; Carvalho CG; Reia VC; Capelozza AL; Santos PS
    J Clin Exp Dent; 2020 Aug; 12(8):e725-e729. PubMed ID: 32913568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.